文献速递肝病

非酒精性脂肪性肝病与骨骼肌质量加速丢失:一项纵向队列研究

Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.
PubMed 文献 · Hepatology · 2022-06-10

这项纵向队列研究纳入52,815名20岁及以上、至少接受两次健康体检(含生物电阻抗分析和腹部超声)的男女性,比较基线有无NAFLD者的5年四肢骨骼肌质量(ASM)变化。无NAFLD者5年ASM变化为-225.2 g(95%CI -232.3, -218.0),NAFLD者为-281.3 g(95%CI -292.0, -270.6),多变量校正后差值为-39.9 g(95%CI -53.1, -26.8);NAFLD合并中高NFS者ASM丢失更快。

要点

  • NAFLD患者5年ASM丢失较无NAFLD者更快,多变量校正后差值为-39.9 g(95%CI -53.1, -26.8)。
  • NAFLD合并中高NFS者ASM丢失较低NFS者更快。
  • 作者认为NAFLD患者可能需要筛查和早期干预以减轻骨骼肌质量丢失。

核心结论

  • NAFLD患者骨骼肌质量丢失更快,提示其肌少症风险增加。
  • 作者认为NAFLD患者可能需要筛查和早期干预以减轻骨骼肌质量丢失。

研究设计与样本

  • 纵向队列研究,纳入52,815名20岁及以上、至少接受两次健康体检(含生物电阻抗分析和腹部超声)的男女性。
  • 采用生物电阻抗分析计算四肢骨骼肌质量(ASM),以超声评估NAFLD,以NAFLD纤维化评分(NFS)评估其严重程度。
  • 采用混合线性模型比较基线有无NAFLD者的5年ASM变化。

主要发现

  • 无NAFLD者5年ASM变化为-225.2 g(95%CI -232.3, -218.0),NAFLD者为-281.3 g(95%CI -292.0, -270.6),p < 0.001。
  • 多变量校正分析中,有无NAFLD者5年ASM变化的差值为-39.9 g(95%CI -53.1, -26.8)。
  • 将NAFLD患者按严重程度进一步分组后,中高NFS者ASM丢失较低NFS者更快。

临床怎么用

  • 作者认为NAFLD患者可能需要筛查和早期干预以减轻骨骼肌质量丢失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Whether subjects with NAFLD are at increased risk of sarcopenia is not well established. APPROACH AND RESULTS: This is a cohort study of 52,815 men and women of 20 years of age or older who underwent at least two health check-up exams with bioelectrical impedance analysis and abdominal ultrasound imaging. Bioelectrical impedance analysis was used to calculate appendicular skeletal muscle mass (ASM). NAFLD was assessed by ultrasonography, and its severity was assessed by the NAFLD fibrosis score (NFS). We estimated the 5-year change in ASM comparing participants with and without NAFLD at baseline using mixed linear models. The 5-year change in ASM in participants without and with NAFLD was -225.2 g (95% CI -232.3, -218.0) and -281.3 g (95% CI -292.0, -270.6), respectively (p < 0.001). In multivariable adjusted analysis, the difference in 5-year change in ASM comparing participants with and without NAFLD was -39.9 g (95% CI -53.1, -26.8). When participants with NAFLD were further divided by NAFLD severity, ASM loss was much faster in participants with NAFLD with intermediate to high NFS than in those with low NFS. CONCLUSIONS: Participants with NAFLD were at increased risk of sarcopenia, indicated by faster loss of skeletal muscle mass. Patients with NAFLD may need screening and early intervention to mitigate skeletal muscle mass loss.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sinn DH, Kang D, Kang M, et al. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study. Hepatology. 2022. PMID: 35588190. doi:10.1002/hep.32578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。